Vall d'Hebron Talks by VHIR 'Genome Editing in Biomedicine in 2023 and beyond'

 Vall d'Hebron Talks by VHIR
  Activitat Online —
16/10/2023
16/10/2023 -- From 09:00h to 11:00h
Organize :
Vall d'Hebron Institut de Recerca (VHIR)
Modality: Online
Share it:

Speaker: Dr. Lluís Montoliu (CNB-CSIC).

Lluis Montoliu is a CSIC Research Scientist at the National Centre for Biotechnology and at the Spanish Research Initiative on Rare Diseases, in Madrid, Spain after working in Heidelberg and Barcelona. He is the Director of the Spanish node of the European Mouse Mutant Archive (EMMA/INFRAFRONTIER). 
At the CNB, since 1997, he leads a research team interested in basic science (genome organization), and in applied biomedical science, using animal models for the study of human rare diseases, such as albinism. He has pioneered the in vivo use of genome-editing CRISPR approaches in Spain. He is the current President of two scientific societies ESPCR and ARRIGE and serves at the boards of additional national and international associations. He is the President of the CSIC Ethics Committee and serves at the Ethics Panel of ERC. Besides research, he is also interested in ethics, education and popular science.Laboratory has generated numerous animal models of human rare diseases, such as albinism, through standard genetic modifications or using CRISPR-Cas9 genome editing tools, whose use in mice he pioneered in Spain. He is the President of the CSIC Ethics Committee and a member of the Ethics Panel at the ERC in Brussels.

Genome editing is firmly progressing to the clinic, with an increasing number of clinical trials following numerous preclinical experiments where a variety of CRISPR-related tools have been assessed. Innovation is also arriving at the level of delivery systems, with the use of nanotechnology, thanks to the great success obtained with the lipid nanoparticles that were used to encapsulate the mRNA encoding the S protein of the coronavirus. This webinar will review where do we stand today in genome editing, aims achieved and remaining challenges.

Host: Dr. Josep Quer Sivila, Main researcher, Liver Diseases, Vall Hebron Institut de Recerca VHIR

Registre Online: https://gencat.zoom.us/webinar/register/WN_zRJXco6JSdqP2ji_Y4DwGg

Related activities

IV Split Liver Transplantation Course: Theoretical and Practical Aspects

03/06/2024 - 09:00
More information

Actualización en el diagnóstico y tratamiento de las enfermedades digestivas

03/07/2024 - 09:00
More information

Preceptorship Hiperoxal·luria primària

Hospital Vall d’Hebron. Edifici General (entrada principal) Planta Baixa Sala 6 de Subdirecció. Pg Vall d'Hebron 119-129. Barcelona
03/14/2024 - 09:00
More information

V360 Simulación en Cirugía Vascular versión 3.0

03/27/2024 - 17:00
Especialistas de Angiología y Cirugía Vascular y residentes en formación con el siguiente perfil: • Médicos en formación en Angiología y Cirugía Vascular de 5º año • Especialista de Angiología y Cirugía Vascular de menos de 10 años de experiencia
More information

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.